Estimating the risk of ovarian cancer

American Family Physician

Volumn 80, Issue 6, 2009, Pages 632-634

  Ebell, Mark H ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; CA 125 ANTIGEN;

ABDOMINAL MASS; ABDOMINAL PAIN; BLOATING; BREAST CANCER; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER RISK; DIAGNOSTIC ACCURACY; FAMILY HISTORY; FEMALE INFERTILITY; GASTROINTESTINAL SYMPTOM; GENE MUTATION; GENETIC COUNSELING; HUMAN; HYSTERECTOMY; LIFESPAN; OBESITY; ORAL CONTRACEPTION; OVARY CANCER; PELVIS PAIN SYNDROME; PREDICTION; PREVENTIVE HEALTH SERVICE; PRIMARY MEDICAL CARE; RISK ASSESSMENT; RISK FACTOR; SHORT SURVEY; SYMPTOM; TRANSVAGINAL ECHOGRAPHY; UNITED STATES; URINARY TRACT; URINARY URGENCY; UTERINE TUBE LIGATION;

EID: 70349195033     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (11)

1. Myers ER, Bastian LA, Havrilesky LJ, et al. Management of adnexal mass. Evid Rep Technol Assess (Full Rep). 2006;(130):1-145.
2. Stratton JF, Pharoah P, Smith SK, Easton D, Ponder BA. A systematic review and meta-analysis of family history and risk of ovarian cancer. Br J Obstet Gynaecol. 1998;105(5):493-499. (Pubitemid 28261378)
3. Kim DJ, Rockhill B, Colditz GA. Validation of the Harvard Cancer Risk Index: a prediction tool for individual cancer risk. J Clin Epidemiol. 2004;57(4):332-340. (Pubitemid 38609271)
4. Hartge P, Whittemore AS, Itnyre J, McGowan L, Cramer D. Rates and risks of ovarian cancer in subgroups of white women in the United States. The Collaborative Ovarian Cancer Group. Obstet Gynecol. 1994;84(5):760-764.
5. Nelson HD, Huffman LH, Fu R, Harris EL. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force [published correction appears in Ann Intern Med. 2005;143(7):547]. Ann Intern Med. 2005;143(5):362-379. (Pubitemid 41266609)
6. U.S. Preventive Services Task Force. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement [published correction appears in Ann Intern Med. 2005;143(5):355-361]. Ann Intern Med. 2005;143(5):355-361.
7. Agency for Healthcare Research and Quality. U.S. Preventive Services Task Force. Screening for Ovarian Cancer. http://www.ahrq.gov/clinic/uspstf/ uspsovar.htm. Accessed February 12, 2009.
8. Goff BA, Mandel LS, Melancon CH, Muntz HG. Frequency of symptoms of ovarian cancer in women presenting to primary care clinics. JAMA. 2004;291(22):2705-2712.
9. Goff BA, Mandel LS, Drescher CW, et al. Development of an ovarian cancer symptom index: possibilities for earlier detection. Cancer. 2007;109(2):221-227. (Pubitemid 46106236)
10. Andersen MR, Goff BA, Lowe KA, et al. Combining a symptoms index with CA 125 to improve detection of ovarian cancer. Cancer. 2008;113(3):484-489.
11. Timmerman D, Testa AC, Bourne T, et al. Simple ultrasound-based rules for the diagnosis of ovarian cancer. Ultrasound Obstet Gynecol. 2008;31(6):681-690.